HB-EGF

You have access
Soluble Factors Involved in Cancer Cell–Macrophage Interaction Promote Breast Cancer Growth
KIMIHIRO YONEMITSU, YUKO MIYASATO, TAKUYA SHIOTA, YUSUKE SHINCHI, YUKIO FUJIWARA, SEIJI HOSAKA, YUTAKA YAMAMOTO and YOSHIHIRO KOMOHARA

Anticancer Research September 2021, 41 (9) 4249-4258; DOI: https://doi.org/10.21873/anticanres.15229
You have access
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
DAISUKE IZUCHI, SATOSHI FUKAGAWA, FUSANORI YOTSUMOTO, KOICHIRO SHIGEKAWA, KENICHI YOSHIKAWA, TOYOFUMI HIRAKAWA, CHIHIRO KIYOSHIMA, NAM SUNG OUK, DAICHI URUSHIYAMA, TAKAHIRO KATSUDA, KOHEI MIYATA, TOMOHIRO ITO, MASAMITSU KURAKAZU, RYOTA ARAKI, AYAKO SANUI, DAISUKE MIYAHARA, MASAHARU MURATA, HIROKO ITO, KYOKO SHIROTA, MASAHIDE KUROKI, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2018, 38 (7) 4347-4351; DOI: https://doi.org/10.21873/anticanres.12735
You have access
HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFR^T790M
FUSANORI YOTSUMOTO, SATOSHI FUKAGAWA, KOHEI MIYATA, SUNG OUK NAM, TAKAHIRO KATSUDA, DAISUKE MIYAHARA, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2017, 37 (7) 3825-3831;
You have access
Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy
SATOSHI FUKAGAWA, FUSANORI YOTSUMOTO, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2017, 37 (7) 3891-3896;
You have access
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
KOHEI MIYATA, FUSANORI YOTSUMOTO, SATOSHI FUKAGAWA, CHIHIRO KIYOSHIMA, NAM SUNG OUK, DAICHI URUSHIYAMA, TOMOHIRO ITO, TAKAHIRO KATSUDA, MASAMITSU KURAKAZU, RYOTA ARAKI, AYAKO SANUI, DAISUKE MIYAHARA, MASAHARU MURATA, KYOKO SHIROTA, HIROSHI YAGI, TADAO TAKONO, KIYOKO KATO, NOBUO YAEGASHI, KOHEI AKAZAWA, MASAHIDE KUROKI, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2017, 37 (7) 3955-3960;
You have access
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer Therapy
SUNG OUK NAM, FUSANORI YOTSUMOTO, KOHEI MIYATA, SATOSHI FUKAGAWA, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, MASAHIDE KUROKI, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2016, 36 (7) 3651-3657;
You have access
Validity of HB-EGF as Target for Human Neuroblastoma Therapy
SUNG OUK NAM, FUSANORI YOTSUMOTO, KOHEI MIYATA, RYOTA SOUZAKI, TOMOAKI TAGUCHI, MASAHIDE KUROKI and SHINGO MIYAMOTO

Anticancer Research August 2015, 35 (8) 4433-4440;
You have access
Pre-clinical Study of BK-UM, a Novel Inhibitor of HB-EGF, for Ovarian Cancer Therapy
SUNG OUK NAM, FUSANORI YOTSUMOTO, KOHEI MIYATA, YUKI SUZAKI, HIROSHI YAGI, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, MASAHIDE KUROKI, EISUKE MEKADA and SHINGO MIYAMOTO

Anticancer Research August 2014, 34 (8) 4615-4620;

Main menu

User menu

Search

HB-EGF